Division of Endocrinology and Molecular Medicine, University of Kentucky, Lexington, KY 40506, USA.
Postgrad Med. 2010 Jan;122(1):201-3. doi: 10.3810/pgm.2010.01.2116.
The efficacy of either detemir or glargine is comparable in subjects with type 2 diabetes when combined with insulin aspart in a basal-bolus regimen. Subjects randomized to detemir used slightly higher daily insulin doses, but gained less weight on average than glargine-treated subjects.
在基础-餐时胰岛素方案中,与门冬胰岛素联合应用时,地特胰岛素或甘精胰岛素的疗效在 2 型糖尿病患者中相当。与甘精胰岛素组相比,随机分配至地特胰岛素组的患者每日胰岛素用量略高,但平均体重增加较少。